BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8350430)

  • 1. Cryopreserved venous allografts: effects of immunosuppression and antiplatelet therapy on patency and function.
    Miller VM; Bergman RT; Gloviczki P; Brockbank KG
    J Vasc Surg; 1993 Aug; 18(2):216-26. PubMed ID: 8350430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreservation affects endothelial and smooth muscle function of canine autogenous saphenous vein grafts.
    Elmore JR; Gloviczki P; Brockbank KG; Miller VM
    J Vasc Surg; 1991 May; 13(5):584-92. PubMed ID: 2027197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional changes in canine saphenous veins after cryopreservation.
    Elmore JR; Gloviczki P; Brockbank KG; Miller VM
    Int Angiol; 1992; 11(1):26-35. PubMed ID: 1522350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cryopreserved allograft venous conduits in dogs.
    Deaton DW; Stephens JK; Karp RB; Gamliel H; Rocco F; Perelman MJ; Liddicoat JR; Glick DB; Watkins CW
    J Thorac Cardiovasc Surg; 1992 Jan; 103(1):153-62. PubMed ID: 1728702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dietary L-arginine on structure and function of flow-restricted vein grafts.
    Landis ME; Ray EC; Gloviczki P; Miller VM
    J Vasc Surg; 2001 Apr; 33(4):829-39. PubMed ID: 11296339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts.
    Buckley CJ; Abernathy S; Lee SD; Arko FR; Patterson DE; Manning LG
    J Vasc Surg; 2000 Oct; 32(4):731-8. PubMed ID: 11013037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of cryopreserved veins. Preliminary report.
    Brockbank KG; Donovan TJ; Ruby ST; Carpenter JF; Hagen PO; Woodley MA
    J Vasc Surg; 1990 Jan; 11(1):94-100; discussion 100-2. PubMed ID: 2296107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy.
    Solanes N; Rigol M; Castellà M; Khabiri E; Ramírez J; Segalés J; Roqué M; Agustí E; Pérez-Villa F; Roig E; Pomar JL; Sanz G; Heras M
    Transplant Proc; 2004 Dec; 36(10):3288-94. PubMed ID: 15686747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses.
    Park TC; Harker CT; Edwards JM; Moneta GL; Taylor LM; Porter JM
    J Vasc Surg; 1993 Jul; 18(1):61-8; discussion 68-9. PubMed ID: 8326660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of cryopreserved canine venous allografts.
    Bank HL; Schmehl MK; Warner R; Pratt MF; Albernaz MS; Metcalf JS; Darcy M
    J Surg Res; 1991 Jan; 50(1):57-64. PubMed ID: 1987432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling transplant vasculopathy in cryopreserved vein grafts with polyethylene glycol and glutathione during transport.
    Davies MG; Huynh TT; Fulton GJ; Svendsen E; Brockbank FG; Hagen PO
    Eur J Vasc Endovasc Surg; 1999 Jun; 17(6):493-500. PubMed ID: 10375485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early results of infrageniculate arterial reconstruction using cryopreserved homograft saphenous conduit (CADVEIN) and combination low-dose systemic immunosuppression.
    Posner MP; Makhoul RG; Altman M; Kimball P; Cohen N; Sobel M; Dattilo J; Lee HM
    J Am Coll Surg; 1996 Sep; 183(3):208-16. PubMed ID: 8784313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial reactivity after transplantation. Differential effects of denervation and rejection.
    Nilsson FN; McGregor CG; Miller VM
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):751-61; discussion 761-2. PubMed ID: 1548917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular repopulation of human vein allograft bypass grafts.
    Johnson TR; Tomaszewski JE; Carpenter JP
    J Vasc Surg; 2000 May; 31(5):994-1002. PubMed ID: 10805891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreserved vein transplantation.
    Brockbank KG; McNally RT; Walsh KA
    J Card Surg; 1992 Jun; 7(2):170-6. PubMed ID: 1606369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lumbar sympathectomy on the properties of both endothelium and smooth muscle cells of the canine femoral artery and autogenous vein grafts under poor runoff conditions.
    Funahashi S; Komori K; Itoh H; Okadome K; Sugimachi K
    J Surg Res; 1996 Aug; 64(2):184-9. PubMed ID: 8812631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft vein patency in a canine model. Additive effects of cryopreservation and cyclosporine.
    Augelli NV; Lupinetti FM; el Khatib H; Sanofsky SJ; Rossi NP
    Transplantation; 1991 Sep; 52(3):466-70. PubMed ID: 1897018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethylsulfoxide-treated, cryopreserved venous allografts in the arterial and venous systems.
    Sitzmann JV; Imbembo AL; Ricotta JJ; McManama GP; Hutchins GM
    Surgery; 1984 Feb; 95(2):154-9. PubMed ID: 6695333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A.
    Vischjager M; Van Gulik TM; Van Marle J; Pfaffendorf M; Jacobs MJ
    J Vasc Surg; 1996 Nov; 24(5):876-82. PubMed ID: 8918337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive treatment of venous allografts.
    Vermassen F; Degrieck N; De Kock L; Goubeau J; Van Landuyt K; Noens L; Derom F
    Eur J Vasc Surg; 1991 Dec; 5(6):669-75. PubMed ID: 1836770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.